Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany.
Institute of Molecular Oncology and Functional Genomics, School of Medicine, Technical University of Munich, Munich, Germany.
Nat Protoc. 2022 Sep;17(9):1903-1925. doi: 10.1038/s41596-022-00700-y. Epub 2022 Jul 15.
Here we provide a detailed tutorial on CRISPR in vivo screening. Using the mouse as the model organism, we introduce a range of CRISPR tools and applications, delineate general considerations for 'transplantation-based' or 'direct in vivo' screening design, and provide details on technical execution, sequencing readouts, computational analyses and data interpretation. In vivo screens face unique pitfalls and limitations, such as delivery issues or library bottlenecking, which must be counteracted to avoid screening failure or flawed conclusions. A broad variety of in vivo phenotypes can be interrogated such as organ development, hematopoietic lineage decision and evolutionary licensing in oncogenesis. We describe experimental strategies to address various biological questions and provide an outlook on emerging CRISPR applications, such as genetic interaction screening. These technological advances create potent new opportunities to dissect the molecular underpinnings of complex organismal phenotypes.
在这里,我们提供了一个关于 CRISPR 体内筛选的详细教程。以小鼠作为模式生物,我们介绍了一系列 CRISPR 工具和应用,阐述了“基于移植”或“直接体内”筛选设计的一般考虑因素,并提供了技术执行、测序结果、计算分析和数据解释的详细信息。体内筛选面临着独特的陷阱和限制,例如输送问题或文库瓶颈,必须加以克服,以避免筛选失败或得出有缺陷的结论。可以研究各种体内表型,如器官发育、造血谱系决策和肿瘤发生中的进化许可。我们描述了用于解决各种生物学问题的实验策略,并展望了新兴的 CRISPR 应用,如遗传相互作用筛选。这些技术进步为剖析复杂生物表型的分子基础创造了强大的新机会。